Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
about
Hepatocellular Carcinoma: Risk Factors, Diagnosis and TreatmentDevelopment and novel therapeutics in hepatocellular carcinoma: a reviewSelection of patients with hepatocellular carcinoma for liver transplantation: Past and futureEndoscopic palliation of malignant biliary stricturesManagement of "very early" hepatocellular carcinoma on cirrhotic patientsCurrent systemic treatment of hepatocellular carcinoma: A review of the literatureInhibitor-Based Therapeutics for Treatment of Viral HepatitisThe Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsHepatocellular Carcinoma: Implications for Asia-Pacific Oncology NursesAnti-hepatocarcinogenic and Anti-oxidant Effects of Mangrove Plant Scyphiphora hydrophyllacea.Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinomaAutophagy inhibits chemotherapy-induced apoptosis through downregulating Bad and Bim in hepatocellular carcinoma cells.Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Extraordinary radiation super-sensitivity accompanying with sorafenib combination therapy: what lies beneath?Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cellsPrognostic factors of spontaneously ruptured hepatocellular carcinomaScreening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literatureTargeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexesPrognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy.Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV.CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinomaSorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma.Radiation-induced liver disease: current understanding and future perspectivesGallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.Abdominal Skin Rash After TACE Due to Non-Target Embolization of Hepatic Falciform Artery.miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.
P2860
Q26747551-D4062217-6A77-4849-8332-04C616FABB7EQ26752854-8FBAEAB5-2AF9-4B95-A7DC-F691B755BFD2Q26771246-C0112A78-10F9-45E5-A48D-CE209CB8F5DEQ26827619-D172DA8B-A59D-4FD3-ABF5-86221C0E9414Q26864406-D8FF1CF4-DA75-493B-8674-38D310B51269Q27026036-2EA75A55-957D-4E66-9458-B06B6C2FB2C4Q28073697-8739A501-CB7B-4C5F-97BA-5ADC1DEB655AQ28820734-1FFD2EF0-5C9A-4C46-BD5E-D6B1D70F0DE9Q30234460-FE189C9B-0572-4D94-B6E4-F892D4BCC013Q33609216-108BA9E6-6270-4AFC-AFEA-FD61AD5C5520Q33730678-B148D954-1324-4F25-9E63-4A8E814A1835Q33781222-845B5EEA-E29C-4468-A92D-ED1FFCFE4050Q33919629-CB374F17-8788-4940-8D3B-CF285BCCC85EQ33919709-821B9297-21CB-4B41-8D41-27ED9EE90D42Q34366102-1176C506-1394-43BA-B3EB-AB5A3F9B2563Q35169325-7F42E666-64A1-43F1-8F9F-0096726B96E1Q35594258-3934A81B-C564-4612-83A9-17E6680B0B3CQ35625384-28C4B8E3-94E2-447E-BE94-2EF796D30DBEQ35742454-E686B44F-5132-4E47-8F60-AE299E61E8E8Q35783915-C06405E5-CC21-43D3-9215-14797F0D7D15Q36000994-01E2E4E8-F836-475B-A0E0-F9C463C4C752Q36085978-46EB58C5-D41D-4635-9418-21DF9CF1213FQ36255362-C5CD5312-6971-4516-8BBF-458DBC4145E9Q36298758-939D4948-AF3C-41E7-B992-F28C62E18F9AQ36666680-DFE5D746-46B9-4C65-8504-40F03E7F17F7Q37012098-D4E804F2-84D3-4B66-AA64-CD8453E6990EQ37159921-8CDCD840-B410-48ED-83F6-865B4BFF5825Q37202324-F138D9CF-ECB7-4445-8FE4-79079D530C46Q37545085-9588C742-8710-4689-97E1-D0E786C7F46CQ37571181-860CC25E-1772-4930-A8FA-6DD2F24AE06DQ37683757-07823566-A108-4C60-AC8B-571463BB4088Q37696388-5316E881-FF2F-4BFF-947E-799FCAA0A657Q37701106-0CAD241C-106B-4660-AB1D-9B1EC855ACE9Q38440403-00314920-C9B9-4111-A95F-DEBAF28021A0Q38654063-308B810D-549A-4766-99DE-48D294ACBED8Q38723821-F62A6117-5C00-4E00-A258-B3F52E8C862BQ38734363-7AA829BD-6ADD-4676-82ED-933BDFDAD1E4Q38825135-4F633D9F-0909-40F4-A829-4A156647A5D3Q38834174-DCD79353-F389-4E93-BB15-57E8B98E6A9CQ38840494-5513F780-1142-45B2-8BD2-B87F98DBBAE7
P2860
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
@en
type
label
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
@en
prefLabel
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
@en
P2860
P356
P1476
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
@en
P2093
Gagan K Sood
P2860
P304
P356
10.3748/WJG.V20.I15.4115
P407
P577
2014-04-01T00:00:00Z